Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

BlackRock Aktie 1005182 / US09247X1019

07.11.2025 22:00:45

XRP Price To Reach $1,000 By End Of 2025? Rumor Mills Are On Fire With BlackRock Speculations

Speculations across the crypto space have ignited a wave of excitement for the XRP price as rumors linking BlackRock, the world’s largest asset manager, and Ripple, a crypto payments company, continue to spread. The possibility of XRP reaching $1,000 before the end of 2025 has become the latest hot topic, fueled by bold claims from top analysts who believe that this rumored partnership could set the stage for one of the most explosive bull runs in this cycle. BlackRock And Ripple Rumors To Send XRP Price To $1,000Crypto market analyst ‘The Real Remi Relief’ has stirred significant interest with his post on X social media, claiming that if ongoing rumors about a potential partnership between BlackRock and Ripple prove true, the XRP price could reach $1,000 by the end of 2025. He advised holders to secure their XRP in cold wallets and prepare for a potential market-wide supply shock. His optimism stems from reports shared by another well-analyst @DelCrxpto, who revealed that sources deep within the crypto industry are hinting at a major development involving BlackRock and Ripple. According to these claims, the global asset manager may be preparing to collaborate with Ripple to establish infrastructure for the tokenization of all $5.3 trillion of its ETF liquidity. If such an initiative were to materialize, it would represent one of the largest integrations of blockchain into global finance. Ripple’s network, designed for fast and cost-effective asset transfers, could provide the foundation for tokenized ETFs, potentially transforming traditional investment markets. Additionally, the crypto payments company, which is already expanding into the Real-World Asset (RWA) tokenization sector, will broaden its technology and services to support a broader range of financial products. The possibility of such a partnership has reignited optimism within the XRP community, especially after the recent Ripple Swell event, which featured participation from prominent names including BlackRock, Nasdaq, Franklin Templeton, The White House, and several other global institutions.Notably, an ETF tokenization deal between Ripple and BlackRock could elevate XRP’s role in the digital asset and financial ecosystem, driving institutional adoption, which could propel its price. Despite growing optimism about XRP’s price outlook, the rumors remain unconfirmed, and neither Ripple nor BlackRock has issued any official statement. XRP Expected To Explode Within The Next 3 MonthsMarket analyst @Steph_iscrypto has added fuel to the bullish excitement surrounding the XRP price with a technical analysis suggesting that the cryptocurrency could soon enter another parabolic phase. He announced in his X post that “XRP will shock everyone in the next 1-3 months.”His accompanying weekly chart highlights bull rallies from past cycles, where XRP surged 2,117% in 2013, 110,466% in 2017, and 1,208% in 2020. Building on this trend, XRP has recently broken through a long-term resistance level, mirroring the early stages of its previous explosive bull cycles. If historical patterns repeat, the analyst suggests that the cryptocurrency could be on the verge of another explosive bull run this cycle. Weiter zum vollständigen Artikel bei NewsBTC

Analysen zu BlackRock Inc.

  • Alle
  • Kaufen
  • Hold
  • Verkaufen
  • ?
Zu diesem Datensatz liegen uns leider keine Daten vor.
Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

Abnehmspritzen – Ist der Hype vorbei? – mit Tim Schäfer

Ist der Hype um Abnehmspritzen wie bei Novo Nordisk und Eli Lilly vorbei – oder stehen wir erst am Anfang einer langfristigen Revolution im Gesundheitswesen? 💉📉

Im heutigen Gespräch mit Tim Schäfer @TimSchaeferMedia sprechen wir über die spannendsten Pharmawerte 2025. Neben den Abnehmspritzen blicken wir auch auf klassische Pharma-Giganten wie Pfizer, Johnson & Johnson, Roche, Novartis, AstraZeneca und GSK. Tim analysiert Übertreibungen, Rücksetzer und langfristige Chancen für Buy-and-Hold-Strategien – mit Fokus auf Dividende, KGV und Krisenresistenz.

💬 Was ist vom Abnehmtrend langfristig zu halten?
💬 Welche Pharma-Aktien sind aktuell unterbewertet?
💬 Was spricht für konservative Dividendenwerte im Gesundheitssektor?

👉🏽 https://bxplus.ch/wall-street-live-mit-tim-schaefer/

Abnehmspritzen – Ist der Hype vorbei? – Wall Street Live mit Tim Schäfer

Mini-Futures auf SMI

Typ Stop-Loss Hebel Symbol
Short 12’777.17 19.37 BWDSCU
Short 13’049.67 13.82 B7ZS2U
Short 13’525.87 8.98 B9GSAU
SMI-Kurs: 12’298.35 07.11.2025 17:31:28
Long 11’775.03 20.00 SIXBJU
Long 11’517.06 13.90 BBWS3U
Long 10’994.16 8.88 S2EBLU
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB), sowie Informationen zu Chancen und Risiken, finden Sie unter: https://keyinvest-ch.ubs.com